Compare EIKN & DGICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EIKN | DGICA |
|---|---|---|
| Founded | 2019 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 631.0M | 714.2M |
| IPO Year | 2026 | 1995 |
| Metric | EIKN | DGICA |
|---|---|---|
| Price | $7.26 | $18.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $24.60 | $21.00 |
| AVG Volume (30 Days) | ★ 626.1K | 101.2K |
| Earning Date | 11-06-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 4.22% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $978,014,322.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.82 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.02 | $16.11 |
| 52 Week High | $16.50 | $21.06 |
| Indicator | EIKN | DGICA |
|---|---|---|
| Relative Strength Index (RSI) | 32.44 | 44.94 |
| Support Level | $7.02 | $17.91 |
| Resistance Level | $10.20 | $19.54 |
| Average True Range (ATR) | 0.54 | 0.38 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 12.21 | 63.39 |
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
Donegal Group Inc is an insurance holding company whose insurance subsidiaries and affiliates offer property and casualty insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states. It includes three segments: Investments Function, Commercial Lines of Insurance, and Personal Lines of Insurance. The majority of revenue is from the commercial Lines segment. The commercial Lines segment consists mainly of commercial automobile, commercial multi-peril, and workers' compensation policies.